91678-23-8

Basic information

• Product Name: 2-BROMO-6-CHLORO-3-NITROPYRIDINE
• Synonyms: 2-BROMO-6-CHLORO-3-NITROPYRIDINE;Pyridine,2-broMo-6-chloro-3-nitro-
• CAS NO: 91678-23-8
• Molecular Formula: C5H2BrClN2O2
• Molecular Weight: 237.43858
• EINECS: 200-589-5
• Product Categories: Heterocycle-Pyridine series
• Mol File: 91678-23-8.mol

Chemical Properties

• Boiling Point: 277.2±35.0℃ (760 Torr)
• Flash Point: 121.5±25.9℃
• Appearance: /
• Density: 1.936±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.00772mmHg at 25°C
• Refractive Index: 1.627
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -7.39±0.10(Predicted)
• CAS DataBase Reference: 2-BROMO-6-CHLORO-3-NITROPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-6-CHLORO-3-NITROPYRIDINE(91678-23-8)
• EPA Substance Registry System: 2-BROMO-6-CHLORO-3-NITROPYRIDINE(91678-23-8)

Safety Data

• Hazardous Substances Data: 91678-23-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-6-chloro-3-nitropyridine is used as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs due to its chemical reactivity and structural properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-6-chloro-3-nitropyridine serves as an intermediate for the production of pesticides and other agrochemicals, leveraging its ability to form a variety of compounds with potential pesticidal activity.
Used in Dye Industry:
2-BROMO-6-CHLORO-3-NITROPYRIDINE is utilized as an intermediate in the synthesis of dyes, where its unique structure and reactivity allow for the creation of a range of colored compounds used in various applications.
Used in Organic Synthesis:
2-Bromo-6-chloro-3-nitropyridine is employed as a versatile building block in organic synthesis, taking advantage of its capacity to undergo multiple types of chemical reactions to form diverse organic compounds.
Environmental Considerations:
Given its potential as an environmental contaminant, 2-Bromo-6-chloro-3-nitropyridine requires careful handling and disposal to mitigate any adverse effects on the environment, emphasizing the need for responsible practices in its use and management.

InChI:InChI=1/C5H2BrClN2O2/c6-5-3(9(10)11)1-2-4(7)8-5/h1-2H

Upstream product

• 27048-04-0 2-amino-6-chloro-3-nitropyridine 

Downstream Products

• 1049706-69-5 2-phenyl-3-nitro-6-chloropyridine 
• 945840-69-7 7-bromo-5-chloro-1H-pyrrolo[2,3-c]pyridine 

Relevant articles and documents

Organic electroluminescent material and device thereof

Disclosed are an organic electroluminescent material and a device thereof. The organic electroluminescent material is a novel triaryl amine-aza-carbazole quinazoline compound. The compound is used asa host material in an electroluminescent device and prov

A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors

The epigenetic regulator CBP/P300 presents a novel therapeutic target for oncology. Previously, we disclosed the development of potent and selective CBP bromodomain inhibitors by first identifying pharmacophores that bind the KAc region and then building into the LPF shelf. Herein, we report the "hybridization" of a variety of KAc-binding fragments with a tetrahydroquinoline scaffold that makes optimal interactions with the LPF shelf, imparting enhanced potency and selectivity to the hybridized ligand. To demonstrate the utility of our hybridization approach, two analogues containing unique Asn binders and the optimized tetrahydroquinoline moiety were rapidly optimized to yield single-digit nanomolar inhibitors of CBP with exquisite selectivity over BRD4(1) and the broader bromodomain family.

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

Heterobicyclic amide compounds

Compounds of formula I processes for their preparation and pharmaceutical compositions comprising them.